Medicure is a value play nowCompany has $127 million tax losses which may be easily valued at $2/share. Company is currently profitable 3-4 cents/share/quarter and likely to increase for next few quarters per company . Approximately 15 cents earnings at 15 p/e ratio add value of 2.25$ imo. It has a FDA approved medication Aggrastat . May be GUD or RX interested in it?